Literature DB >> 26505452

Polymorphic variations in manganese superoxide dismutase (MnSOD) and endothelial nitric oxide synthase (eNOS) genes contribute to the development of type 2 diabetes mellitus in the Chinese Han population.

J Y Li1, F Tao1, X X Wu2, Y Z Tan1, L He3, H Lu1.   

Abstract

Impaired antioxidant defense increases the oxidative stress and contributes to the development of type 2 diabetes mellitus (T2DM). MnSOD and eNOS are important antioxidant enzymes. This aim of this study was to verify the association of MnSOD and eNOS tagSNPs with T2DM in a Chinese Han population. Four tagSNPs of MnSOD and eight tagSNPs of eNOS were detected using TaqMan technology in 1272 healthy controls and 1234 T2DM patients. All study participants were unrelated members of the Han ethnic group in China. In this study, the frequency of the rs4880 MnSOD single nucleotide polymorphisms (SNP) genotype differed significantly between T2DM patients and controls [allele: P = 0.03, genotype: P = 0.04, odd's ratio (OR) = 1.26; 95% confidence interval (CI) = 1.07-1.49]. The A-T haplotype and G-T haplotype remained significant in T2DM after Bonferroni correction (P = 1.58 x 10(-6) and 8.00 x 10(-4), respectively) with a global p-value of 7.25 x 10(-8). The rs1799983 and rs891512 SNPs of eNOS differed significantly between T2DM patients and controls [rs1799983: corrected allele: P = 2.10 x 10(-3), corrected genotype: P = 6.30 x 10(-3), OR = 1.43 (95%CI = 1.18-1.73); rs891512, corrected allele: P = 3.50 x 10(-3), corrected genotype: P = 9.10 x 10(-3), OR = 1.70 (95%CI = 1.26-2.30)]. Following Bonferroni correction, none of the haplotypes of eNOS were significant in T2DM. These results indicate that common variants in MnSOD and eNOS increased the risk of T2DM in the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26505452     DOI: 10.4238/2015.October.21.20

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  6 in total

1.  Association of nitric oxide synthase 3 gene polymorphism with the risk of type 2 diabetes.

Authors:  Yasaman Garme; Ramin Saravani; Hamid Reza Galavi
Journal:  Biomed Rep       Date:  2017-05-22

2.  Evaluation of Association Studies and Meta-Analyses of eNOS Polymorphisms in Type 2 Diabetes Mellitus Risk.

Authors:  Di Wang; Liangshu Liu; Chengyu Zhang; Wensheng Lu; Feifei Wu; Xiaofeng He
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

3.  Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia.

Authors:  Aslı Tetik Vardarlı; Ece Harman; Vildan Bozok Çetintaş; Meral Kayıkçıoğlu; Egemen Vardarlı; Ayhan Zengi; Ali Şahin Küçükaslan; Zuhal Eroğlu
Journal:  Anatol J Cardiol       Date:  2017-03-03       Impact factor: 1.596

4.  Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain.

Authors:  Dario Kringel; Mari A Kaunisto; Catharina Lippmann; Eija Kalso; Jörn Lötsch
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

5.  A Genetic Score of Predisposition to Low-Grade Inflammation Associated with Obesity May Contribute to Discern Population at Risk for Metabolic Syndrome.

Authors:  Sebastià Galmés; Margalida Cifre; Andreu Palou; Paula Oliver; Francisca Serra
Journal:  Nutrients       Date:  2019-01-30       Impact factor: 5.717

6.  Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases the risk of depression and self-reported psychological stress in free-living elderly people.

Authors:  Ivo Emilio da Cruz Jung; Ivana Beatrice Mânica da Cruz; Fernanda Barbisan; Alexis Trott; Lucien J Houenou; Bárbara Osmarin Turra; Thiago Duarte; Raquel de Souza Praia; Ednea Aguiar Maia-Ribeiro; Jaqueline da Costa Escobar Piccoli; Claudia Giugliano Bica; Marta Maria Medeiros Frescura Duarte
Journal:  Mol Genet Genomic Med       Date:  2019-12-31       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.